|
Recruiting
|
NCT05537558 -
Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)
|
|
|
Terminated
|
NCT02192099 -
Open Label Extension for GLYX13-C-202, NCT01684163
|
Phase 2 |
|
Completed
|
NCT03142919 -
Lipopolysaccharide (LPS) Challenge in Depression
|
Phase 2 |
|
Recruiting
|
NCT05547035 -
Identification of Physiological Data by a Wearable Monitor in Subjects Suffering From Major Depression Disorders
|
N/A |
|
Terminated
|
NCT02940769 -
Neurobiological Effects of Light on MDD
|
N/A |
|
Recruiting
|
NCT05892744 -
Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression
|
Phase 4 |
|
Recruiting
|
NCT05537584 -
SMART Trial to Predict Anhedonia Response to Antidepressant Treatment
|
Phase 4 |
|
Active, not recruiting
|
NCT05061706 -
Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
|
Phase 3 |
|
Completed
|
NCT04479852 -
A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder
|
Phase 2 |
|
Recruiting
|
NCT04032301 -
Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
|
Phase 1 |
|
Recruiting
|
NCT05527951 -
Enhanced Measurement-Based Care Effectiveness for Depression (EMBED) Study
|
N/A |
|
Completed
|
NCT03511599 -
Cycloserine rTMS Plasticity Augmentation in Depression
|
Phase 1 |
|
Recruiting
|
NCT04392947 -
Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation
|
N/A |
|
Recruiting
|
NCT05895747 -
5-HTP and Creatine for Depression R33 Phase
|
Phase 2 |
|
Recruiting
|
NCT05273996 -
Predictors of Cognitive Outcomes in Geriatric Depression
|
Phase 4 |
|
Recruiting
|
NCT05813093 -
Interleaved TMS-fMRI in Ultra-treatment Resistant Depression
|
N/A |
|
Recruiting
|
NCT05135897 -
The Neurobiological Fundaments of Depression and Its Relief Through Neurostimulation Treatments
|
|
|
Enrolling by invitation
|
NCT04509102 -
Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder
|
Early Phase 1 |
|
Recruiting
|
NCT06145594 -
EMA-Guided Maintenance TMS for Depression
|
N/A |
|
Recruiting
|
NCT06026917 -
Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)
|
Phase 4 |